news_6

BeiGene Announces Positive Topline Results from Phase 3 SEQUOIA Trial Comparing BRUKINSA® (Zanubrutinib) to Bendamustine Plus Rituximab in Patients with Treatment-Naïve Chronic Lymphocytic Leukemia

Trial met the primary endpoint at interim analysis, with BRUKINSA significantly prolonging progression-free survival compared to chemoimmunotherapy and safety and...

news_6

INVESTOR ALERT: Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed Against Oatly Group AB and Encourages Investors to Contact the Firm Before September 24, 2021

news_6

Alnylam and PeptiDream Enter into Collaboration Agreement to Discover and Develop Peptide-siRNA Conjugates for Targeted Delivery of RNAi Therapeutics to a Broader Range of Extrahepatic Tissues

? Agreement Combines PeptiDream’s Peptide Discovery Platform to Identify High Affinity Peptide Ligands with Alnylam’s Expertise in siRNA-Conjugate-Based Delivery and...

news_6

ASEAN Mobility Start-Up Growth Opportunities Report 2021 Featuring Airovr, Angkas, Bussr, FastGo, Gesits, mobilityX, MooVita, Oyika, SERV, VinFast – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "ASEAN Mobility Start-Up Growth Opportunities" report has been added to ResearchAndMarkets.com's offering. This study assesses the mobility start-up...